Clinical technologies to reduce HCAIs

The company’s employees are focused on developing and bringing to market solutions to today’s major healthcare challenges, including healthcare-associated infections (HCAIs). The CareFusion Infection Prevention mission is to deliver clinically differentiated, evidence-based products and services that support the global effort to reduce HCAIs. ChloraPrep is illustrative of this focus. The only 2% Chlorhexidine based product licensed for cutaneous antisepsis prior to medical and surgical invasive procedures, it allows healthcare professionals to comply with evidence-based guidelines and recognised best practice for prevention of HCAIs – thereby helping to save lives.